| | ATP8A2, ATXN8OS +2049 more | Copy number loss | See cases | |
| | LOC130009892, LOC130009893 +2050 more | Copy number gain | See cases | |
| | LOC130009819, LOC130009820 +2048 more | Copy number gain | See cases | |
| | LOC130009419, LOC130009420 +567 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LOC126861730, LOC126861731 +489 more | Copy number gain | See cases | |
| | LOC130009309, LOC130009310 +2041 more | Copy number gain | See cases | |
| | LOC130009607, LOC130009608 +2029 more | Copy number gain | See cases | |
| | LOC132090185, LOC132090186 +621 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LOC130009383, LOC130009384 +2022 more | Copy number gain | See cases | |
| | LOC126861859, LOC126861860 +2025 more | Copy number gain | See cases | |
| | LOC112163664, LOC112163665 +2025 more | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number gain | See cases | |
| | LINC00426, LINC00427 +118 more | Copy number loss | See cases | |
| | | Copy number loss | See cases | |
| | LOC130009567, LOC130009568 +1005 more | Copy number gain | See cases | |
| | LOC130009620, LOC130009621 +781 more | Copy number loss | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LOC130009600, LOC130009601 +735 more | Copy number gain | See cases | |
| | BRCA2, LOC106721785 +1 more | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | BRCA2, LOC106721785 +1 more | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +1 more | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | BRCA2, LOC106721785 +1 more | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | LOC106721785, ZAR1L +1 more | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +2 more | Deletion | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Single nucleotide variant | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant | Hereditary cancer-predisposing syndrome +3 more | |
| | | Duplication | not provided | |
| | | Deletion | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +1 more | Deletion | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +1 more | Deletion | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +3 more | Deletion | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +1 more | Deletion | Hereditary breast ovarian cancer syndrome | |
| | LOC130009524, LOC106721785 +3 more | Deletion | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +1 more | |
| | | Single nucleotide variant | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Duplication | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Familial cancer of breast | |
| | | Insertion (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Deletion (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Insertion (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Deletion (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | not specified +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Indel (5 prime UTR variant) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (5 prime UTR variant) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Deletion (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Deletion (splice donor variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (splice donor variant) | Fanconi anemia complementation group D1 +2 more | GConflicting classifications of pathogenicity |
| | | Deletion (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Microsatellite (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Microsatellite (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome +1 more | |